22 completed, 19 unknown, 7 recruiting, 5 not yet recruiting. 19 Not applicable, 8 Phase 3, 7 Phase 4, 6 Phase 2, 1 Phase 1.
Follow Portal Vein Thrombosis: new trials by email Literature Review of Portal Vein Thrombosis trials Research Report on Portal Vein Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis Rivaroxaban - Portal Vein Thrombosis, Anticoagulant Therapy | Not applicable | Not yet recruiting | Shanghai Zhongshan Hospital | 175 | 2026-06-01 | 2026-05-22 |
| Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS Apixaban 2.5 MG - Cirrhosis, Splenectomy | Not applicable | Recruiting | Northern Jiangsu People's Hospital | 20 | 2026-04-01 | 2026-03-31 |
| Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD Apixaban 2.5 MG - Cirrhosis, Splenectomy | Not applicable | Recruiting | Northern Jiangsu People's Hospital | 20 | 2026-04-01 | 2026-03-31 |
| Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis Apixaban, Carvedilol, Placebo - Cirrhosis, Esophageal and Gastric Varices | Phase 4 | Recruiting | Asian Institute Of Medical Sciences | 220 | 2026-04-01 | 2026-04-09 |
| Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation Portal Vein Thrombosis, Liver Cirrhosis | Not yet recruiting | Peking University First Hospital | 2522 | 2026-02-01 | 2026-02-20 | |
| Safety of Anticoagulation Therapy in Cirrhotic Patients With PVT and Severe Thrombocytopenia Anticoagulation Therapy - Thrombocytopenia Related to Chronic Liver Disease, Anticoagulation Treatment | Completed | Qilu Hospital of Shandong University | 304 | 2025-09-01 | 2026-10-21 | |
| Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient endoscopic ultrasound-guided portal pressure gradient - Portal Vein Thrombosis, Portal Hypertension Related to Cirrhosis | Not applicable | Not yet recruiting | Zhejiang University | 42 | 2025-07-01 | 2025-07-14 |
| Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors Abdominal US, Doppler US and abdominal multi-slice computed tomography (MSCT) with contrast was performed - Liver Cirrhosis, Portal Vein Thrombosis | Active not recruiting | Elham Ahmed Hassan | 240 | 2025-06-01 | 2026-05-01 | |
| Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis Dabigatran, Enoxaparin - Portal Vein Thrombosis, Liver Cirrhosis | Phase 2 / Phase 3 | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 120 | 2025-01-31 | 2025-02-10 |
| Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT TIPS, Nadroparin - Portal Vein Thrombosis | Not applicable | Unknown | Shanghai Zhongshan Hospital | 84 | 2024-05-01 | 2024-03-21 |
| Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis Warfarin 3 mg, Warfarin 2 mg - Liver Cirrhosis, Portal Vein Thrombosis | Phase 4 | Completed | Kafrelsheikh University | 21 | 2024-03-15 | 2026-05-06 |
| Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis preemptive TIPS, standard second prophylaxis - Portal Hypertension, Portal Vein Thrombosis | Not applicable | Not yet recruiting | West China Hospital | 120 | 2024-01-01 | 2023-11-08 |
| Portal Vein Thrombosis in Neonate With Umbilical Catheter ultrasound and doppler - Portal Vein Thrombosis | Unknown | Assiut University | 45 | 2023-12-20 | 2023-12-06 | |
| Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children endoscopy - Portal Vein Thrombosis | Unknown | Assiut University | 30 | 2023-11-01 | 2023-11-07 | |
| Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC Enoxaparin, warfarrin, or apixaban - Cirrhosis, HCC - Hepatocellular Carcinoma | Phase 4 | Recruiting | Mansoura University | 100 | 2023-08-15 | 2025-08-20 |
| H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis Recombinant human adenovirus type 5 + TACE - Primary Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 38 | 2023-06-01 | 2023-05-24 |
| Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion PBT and atezolizumab/bevacizumab - Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Completed | Samsung Medical Center | 63 | 2023-01-15 | 2026-04-23 |
| Freiburg TIPS Registry Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) - Liver Cirrhosis, Portal Hypertension | Recruiting | University Hospital Freiburg | 2000 | 2023-01-01 | 2026-05-01 | |
| IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation intensity-modulated radiotherapy, Pembrolizumab, Sintilimab - Liver Cancer, Liver Transplant; Complications | Not applicable | Unknown | RenJi Hospital | 78 | 2022-05-20 | 2022-04-27 |
| HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT HAIC, Lenvatinib 1, PD-1 Inhibitors - Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Completed | Peking University | 66 | 2022-01-10 | 2026-01-23 |
Showing 20 of 61. Sign in to see all of them.
Liver Cirrhosis (18) · Carcinoma, Hepatocellular (11) · Hypertension, Portal (10) · Fibrosis (8) · Budd-Chiari Syndrome (3) · Thrombosis (3) · Esophageal and Gastric Varices (2) · Liver Neoplasms (2) · Mesenteric Ischemia (2) · Portal Vein, Cavernous Transformation Of (2) · Angiomyolipoma (1) · Ascites (1) · Biliary Tract Neoplasms (1) · Endoleak (1) · Hemorrhage (1)
Digestive System Diseases (42) · Liver Diseases (39) · Pathologic Processes (28) · Pathological Conditions, Signs and Symptoms (28) · Fibrosis (18) · Neoplasms (13) · Digestive System Neoplasms (12) · Neoplasms by Histologic Type (12) · Neoplasms by Site (12) · Adenocarcinoma (11) · Carcinoma (11) · Neoplasms, Glandular and Epithelial (11) · Cardiovascular Diseases (9) · Liver Neoplasms (9) · Vascular Diseases (9)
Warfarin (7) · Nadroparin (5) · Portasystemic Shunt, Transjugular Intrahepatic (5) · apixaban (5) · Enoxaparin (4) · Rivaroxaban (4) · Dabigatran (2) · Endoscopy (2) · Propranolol (2) · Sorafenib (2) · Ultrasonography, Doppler (2) · Acenocoumarol (1) · Anticoagulation Bridge (1) · Antithrombin III (1) · Bevacizumab (1)
Shanghai Zhongshan Hospital (6) · Air Force Military Medical University, China (3) · Institute of Liver and Biliary Sciences, India (3) · Qilu Hospital of Shandong University (3) · Assiut University (2) · Mansoura University (2) · Northern Jiangsu People's Hospital (2) · Peking University (2) · The Affiliated Hospital of Qingdao University (2) · Academic and Community Cancer Research United (1) · Asian Institute Of Medical Sciences (1) · Assistance Publique - Hôpitaux de Paris (1) · Assuta Medical Center (1) · Centre Hospitalier Universitaire de Nice (1) · Elham Ahmed Hassan (1)
China (24) · Egypt (5) · India (4) · France (3) · Italy (3) · United States (3) · Canada (2) · South Korea (2) · Austria (1) · Brazil (1) · Germany (1) · Israel (1) · Japan (1) · Mexico (1) · Pakistan (1)
Dou-Sheng Bai (2) · Shiyao Chen, Professor (2) · Yanjing Gao, PhD.MD (2) · Aldo Torre Delgadillo (1) · Amr Hanafy, Professor (1) · Ashraf Mohammed Alsagheer, Lecturer (1) · Daniel Kopac, MD MSc (1) · Dominik Bettinger, MD (1) · Dr. Fatima Nadeem, Pharm-D, Mphil (1) · Elvan O Kirimker, MD (1) · Francesco Violi, MD (1) · Gino R Corrazza, MD (1) · Guiqiang Wang (1) · Guohong Han (1) · Guohong Han, MD (1)
PMID 21475421, PMID 23847271, PMID 25759969, PMID 25847227, PMID 26491529, PMID 26774179, PMID 27026379, PMID 27773725, PMID 28837207, PMID 28970291, PMID 29329568, PMID 29886103, PMID 31630479, PMID 32615178, PMID 33089892, PMID 35103539, PMID 35439303, PMID 39025130, PMID 39242398, PMID 39807082, PMID 40105912, PMID 40392481, PMID 41204773, PMID 41910605
2009 (1)